Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 621,961
  • Shares Outstanding, K 39,290
  • Annual Sales, $ 910 K
  • Annual Income, $ -58,130 K
  • 36-Month Beta 2.91
  • Price/Sales 693.07
  • Price/Cash Flow N/A
  • Price/Book 4.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.57
  • Number of Estimates 4
  • High Estimate -0.49
  • Low Estimate -0.74
  • Prior Year -0.43
  • Growth Rate Est. (year over year) -32.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.39 +4.87%
on 12/10/18
19.69 -18.05%
on 11/12/18
-3.53 (-17.95%)
since 11/09/18
3-Month
15.39 +4.87%
on 12/10/18
24.30 -33.58%
on 09/21/18
-4.60 (-22.18%)
since 09/11/18
52-Week
11.46 +40.84%
on 04/04/18
24.30 -33.58%
on 09/21/18
+3.60 (+28.71%)
since 12/11/17

Most Recent Stories

More News
Alternatives to Watch

HENDERSON, NV / ACCESSWIRE / December 10, 2018 / Below are several companies positioning themselves to be a viable opioid alternative.

CARA : 16.05 (+1.39%)
COLL : 19.18 (-0.10%)
TTNP : 0.27 (-3.57%)
INSY : 5.20 (+1.17%)
ENDV : 0.0210 (-12.13%)
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 7.92 (-0.50%)
EPAY : 50.30 (+0.78%)
EXAS : 70.53 (+1.41%)
WYNN : 108.54 (+2.16%)
HMSY : 34.67 (+1.79%)
GLT : 11.52 (-1.79%)
MHK : 121.28 (+1.08%)
BBW : 5.02 (-0.79%)
CDW : 91.84 (+1.35%)
COUP : 65.13 (+0.87%)
QTWO : 49.72 (+1.02%)
DENN : 16.93 (+4.64%)
MYL : 30.34 (+0.13%)
DFRG : 6.46 (-3.87%)
GCAP : 7.56 (+5.29%)
FEYE : 19.04 (-3.59%)
MXIM : 54.21 (+1.65%)
POL : 30.94 (+0.78%)
AN : 34.66 (+2.61%)
TWO : 14.28 (+0.21%)
HUBG : 41.21 (+2.06%)
AR : 13.06 (+2.11%)
RE : 228.74 (-0.62%)
NNBR : 7.22 (+4.79%)
ARE : 127.30 (+1.22%)
CVI : 36.78 (-0.24%)
CERS : 5.54 (+0.54%)
NDAQ : 88.61 (+1.73%)
ELLI : 65.39 (+2.12%)
BLDR : 11.82 (+2.16%)
EGRX : 44.64 (+0.45%)
RGLD : 77.43 (-0.81%)
PRGO : 59.92 (+1.84%)
PENN : 22.77 (-0.04%)
NTAP : 64.85 (-1.19%)
IBM : 122.79 (+1.37%)
NTRI : 44.12 (+1.01%)
BANR : 58.82 (+1.24%)
CWT : 46.85 (+0.45%)
STAA : 35.29 (+2.92%)
ATHN : 133.12 (+0.47%)
CL : 64.71 (+1.84%)
TFSL : 16.12 (-1.29%)
UFPI : 27.05 (+1.77%)
SDRL : 12.34 (-4.19%)
GOV : 8.53 (+1.55%)
HQY : 67.82 (+0.22%)
IPGP : 123.87 (+0.63%)
MINI : 34.81 (+3.66%)
CMTL : 25.14 (-2.22%)
CHD : 67.52 (+1.41%)
GPI : 52.00 (+2.04%)
HRL : 45.13 (+1.97%)
RARE : 47.39 (-0.48%)
MLI : 24.04 (+3.80%)
GPS : 27.78 (+3.04%)
CHS : 5.91 (-0.34%)
RYAM : 12.98 (-1.59%)
PBI : 7.08 (+2.61%)
NUVA : 56.51 (+0.86%)
IMDZ : 2.00 (-2.91%)
CAMP : 14.50 (-14.66%)
NOC : 272.36 (+0.79%)
AEL : 30.04 (+1.69%)
EBIX : 47.28 (-1.34%)
DISCA : 28.40 (+0.11%)
GPOR : 10.05 (+5.57%)
BGS : 30.77 (+2.91%)
TECH : 157.87 (+1.44%)
PCH : 35.25 (-0.09%)
NOV : 29.21 (+0.17%)
TECD : 86.94 (+0.44%)
DISCK : 26.24 (-0.61%)
DECK : 127.93 (+2.60%)
NOW : 184.42 (-0.26%)
MGLN : 59.83 (+3.33%)
IEX : 135.55 (+0.87%)
PTC : 86.56 (+1.45%)
AVT : 41.13 (-1.53%)
RGS : 16.72 (+5.36%)
BSFT : 54.95 (+0.09%)
FOSL : 17.25 (+2.92%)
WAL : 40.72 (+0.67%)
IVR : 15.68 (+0.77%)
ENR : 48.83 (+4.20%)
ISBC : 11.60 (+0.43%)
SHOO : 29.72 (+2.31%)
HDP : 16.43 (-1.02%)
AWK : 97.39 (-0.07%)
OMED : 0.91 (-2.15%)
LADR : 17.23 (+0.82%)
BIG : 30.52 (+2.97%)
WY : 25.72 (+0.12%)
JBLU : 18.15 (+1.11%)
GNMK : 4.81 (-0.21%)
FORM : 15.41 (+0.92%)
PFSI : 21.69 (+0.84%)
NEWM : 12.70 (+0.71%)
KFRC : 30.46 (+2.08%)
HOLX : 42.81 (+1.01%)
TMK : 79.11 (+0.24%)
AXTA : 23.21 (-0.17%)
PGEM : 21.65 (unch)
CLH : 56.62 (+3.45%)
CLI : 21.57 (+0.05%)
NRG : 41.94 (+3.33%)
CLGX : 38.35 (+0.95%)
SFLY : 45.70 (+1.35%)
ICUI : 237.55 (+0.91%)
CARA : 16.05 (+1.39%)
WTR : 35.40 (+0.48%)
NTGR : 52.26 (+0.75%)
OLED : 97.42 (+2.21%)
VNDA : 27.26 (-4.92%)
HIBB : 15.03 (+0.13%)
FFBC : 26.27 (+2.54%)
DLTR : 85.02 (+1.43%)
EQT : 20.62 (+5.04%)
OMER : 14.03 (+1.30%)
KTOS : 14.93 (+2.47%)
SRCL : 42.98 (+1.58%)
GES : 22.28 (+0.95%)
KMX : 63.61 (+2.04%)
PLAB : 9.47 (+3.72%)
NCS : 11.04 (+2.03%)
MAR : 110.29 (-0.47%)
MRVL : 15.63 (+1.82%)
UAL : 88.07 (-0.54%)
CNK : 40.26 (+2.08%)
NATH : 70.60 (-0.35%)
TPH : 11.66 (+1.39%)
OCUL : 5.88 (+5.00%)
SKYW : 48.34 (-0.35%)
HIVE : 3.60 (+2.27%)
GAIA : 11.58 (+0.09%)
ESRX : 96.66 (+0.68%)
PHM : 26.04 (+1.88%)
EBS : 68.93 (+2.88%)
CACI : 162.44 (+2.00%)
SAVE : 61.85 (+2.37%)
EZPW : 8.74 (+0.58%)
TPX : 51.80 (+1.59%)
KLAC : 94.61 (+2.52%)
ULTA : 250.72 (-0.15%)
WWE : 76.62 (+0.82%)
ESV : 4.70 (-1.05%)
LTRPA : 19.00 (+2.76%)
DAL : 56.25 (-0.12%)
BMY : 52.65 (+0.13%)
ECL : 156.28 (+1.09%)
CHRW : 88.72 (+1.02%)
WWW : 33.57 (+1.67%)
ETH : 19.83 (+2.27%)
IART : 50.21 (+1.56%)
LE : 13.84 (-5.27%)
LH : 142.97 (+2.45%)
HZO : 20.09 (+0.45%)
MTD : 603.57 (+2.01%)
OSTK : 18.69 (-0.90%)
LDOS : 60.26 (+1.31%)
SAGE : 111.04 (+3.25%)
CIEN : 31.79 (-0.22%)
MTW : 16.54 (+2.80%)
AMC : 15.12 (+5.73%)
NDLS : 7.55 (+1.62%)
EFII : 26.65 (+3.78%)
SIVB : 205.59 (+0.68%)
MU : 35.90 (+3.16%)
DSW : 25.33 (+9.51%)
VRNT : 46.02 (+2.65%)
OII : 15.03 (-0.13%)
SAFM : 102.15 (+1.89%)
DATA : 127.00 (-0.10%)
TLYS : 11.47 (+0.35%)
TREE : 244.89 (+2.38%)
TRUP : 26.83 (+1.98%)
AMCX : 58.82 (+1.99%)
EXPD : 71.81 (+0.83%)
SUPN : 37.80 (-0.29%)
NBIX : 87.00 (+1.39%)
SAIC : 71.02 (+1.85%)
CBM : 44.71 (+0.54%)
BURL : 162.66 (+1.84%)
AMED : 130.76 (+1.22%)
EXPR : 5.81 (-0.51%)
SBH : 19.38 (+0.57%)
ATSG : 17.85 (-0.89%)
PLT : 39.44 (+1.65%)
QDEL : 50.75 (+5.77%)
NLNK : 1.79 (+2.79%)
STMP : 167.35 (-3.16%)
IPCC : 142.80 (+0.32%)
BMTC : 36.39 (+0.55%)
STML : 10.79 (+4.25%)
EGL : 31.86 (+1.34%)
LUV : 51.11 (-0.06%)
CCL : 56.55 (+0.35%)
INOV : 12.50 (-2.72%)
COTY : 7.72 (+1.71%)
MGM : 26.32 (+1.94%)
AKBA : 9.06 (+1.91%)
LGIH : 42.53 (-0.89%)
CDNS : 44.29 (+2.10%)
CRZO : 14.79 (+1.16%)
TEN : 30.21 (+3.46%)
HAIN : 19.44 (+1.36%)
Opioid Alternatives Could Make Investors Major Gains

HENDERSON, NV / ACCESSWIRE / November 21, 2018 / Moderna and Synthorx's huge IPOs show biotech point to a strong biotech sector that should continue a bull run heading into the new year. CBD based biotechs...

CARA : 16.05 (+1.39%)
ARNA : 41.37 (+0.88%)
ENDV : 0.0210 (-12.13%)
ZYNE : 4.72 (+2.16%)
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates

Cara (CARA) delivered earnings and revenue surprises of -10.87% and 7.34%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

CARA : 16.05 (+1.39%)
Cara: 3Q Earnings Snapshot

STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Tuesday reported a loss of $19.4 million in its third quarter.

CARA : 16.05 (+1.39%)
Cara Therapeutics Reports Third Quarter 2018 Financial Results

- Conference call today at 4:30 p.m. ET -

CARA : 16.05 (+1.39%)
Cara Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral...

CARA : 16.05 (+1.39%)
Direct Selling Returns as Functional Cannabis Foods Fare Well Amid Landmark Legalization

NEW YORK, October 23, 2018 /PRNewswire/ --

CARA : 16.05 (+1.39%)
YGYI : 6.30 (-1.56%)
INSY : 5.20 (+1.17%)
ABBV : 88.37 (+0.87%)
ZYNE : 4.72 (+2.16%)
Cara Therapeutics Appoints Joana Goncalves, M.D., as Chief Medical Officer

- Former VP of Medical Affairs for Dermatology at Celgene to lead development of KORSUVA(TM) in dermatological conditions -

CARA : 16.05 (+1.39%)
Investor Expectations to Drive Momentum within Teradata, Liberty TripAdvisor, CPI Card Group, Cara Therapeutics, Ocular Therapeutix, and G-III Apparel Group, LTD -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Teradata Corporation (NYSE:TDC),...

TDC : 37.33 (+1.74%)
CARA : 16.05 (+1.39%)
GIII : 31.36 (+1.42%)
PMTS : 2.95 (-1.67%)
LTRPB : 18.70 (unch)
LTRPA : 19.00 (+2.76%)
OCUL : 5.88 (+5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade CARA with:

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

2nd Resistance Point 17.00
1st Resistance Point 16.42
Last Price 16.05
1st Support Level 15.32
2nd Support Level 14.80

See More

52-Week High 24.30
Fibonacci 61.8% 19.40
Fibonacci 50% 17.88
Fibonacci 38.2% 16.36
Last Price 16.05
52-Week Low 11.46

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar